|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.
The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on April 16, 2021. The analyst firm set a price target for 14.00 expecting GALT to rise to within 12 months (a possible 434.35% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.62 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Galectin Therapeutics.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.